ArticleCancer science2016

Invariant NKT cells are resistant to circulating CD15+ myeloid-derived suppressor cells in patients with head and neck cancer.

Atsushi Horinaka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.